Copyright Reports & Markets. All rights reserved.

Global Follicular Lymphoma Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Chemotherapy
      • 1.4.3 Radiotherapy
      • 1.4.4 Monoclonal Antibodies
      • 1.4.5 Stem Cell Transplantation
    • 1.5 Market by Application
      • 1.5.1 Global Follicular Lymphoma Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Follicular Lymphoma Treatment Market Size
    • 2.2 Follicular Lymphoma Treatment Growth Trends by Regions
      • 2.2.1 Follicular Lymphoma Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Follicular Lymphoma Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Follicular Lymphoma Treatment Market Size by Manufacturers
      • 3.1.1 Global Follicular Lymphoma Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Follicular Lymphoma Treatment Key Players Head office and Area Served
    • 3.3 Key Players Follicular Lymphoma Treatment Product/Solution/Service
    • 3.4 Date of Enter into Follicular Lymphoma Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Follicular Lymphoma Treatment Market Size by Type (2014-2019)
    • 4.2 Global Follicular Lymphoma Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Follicular Lymphoma Treatment Market Size (2014-2019)
    • 5.2 Follicular Lymphoma Treatment Key Players in United States
    • 5.3 United States Follicular Lymphoma Treatment Market Size by Type
    • 5.4 United States Follicular Lymphoma Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Follicular Lymphoma Treatment Market Size (2014-2019)
    • 6.2 Follicular Lymphoma Treatment Key Players in Europe
    • 6.3 Europe Follicular Lymphoma Treatment Market Size by Type
    • 6.4 Europe Follicular Lymphoma Treatment Market Size by Application

    7 China

    • 7.1 China Follicular Lymphoma Treatment Market Size (2014-2019)
    • 7.2 Follicular Lymphoma Treatment Key Players in China
    • 7.3 China Follicular Lymphoma Treatment Market Size by Type
    • 7.4 China Follicular Lymphoma Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Follicular Lymphoma Treatment Market Size (2014-2019)
    • 8.2 Follicular Lymphoma Treatment Key Players in Japan
    • 8.3 Japan Follicular Lymphoma Treatment Market Size by Type
    • 8.4 Japan Follicular Lymphoma Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Follicular Lymphoma Treatment Market Size (2014-2019)
    • 9.2 Follicular Lymphoma Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Follicular Lymphoma Treatment Market Size by Type
    • 9.4 Southeast Asia Follicular Lymphoma Treatment Market Size by Application

    10 India

    • 10.1 India Follicular Lymphoma Treatment Market Size (2014-2019)
    • 10.2 Follicular Lymphoma Treatment Key Players in India
    • 10.3 India Follicular Lymphoma Treatment Market Size by Type
    • 10.4 India Follicular Lymphoma Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Follicular Lymphoma Treatment Market Size (2014-2019)
    • 11.2 Follicular Lymphoma Treatment Key Players in Central & South America
    • 11.3 Central & South America Follicular Lymphoma Treatment Market Size by Type
    • 11.4 Central & South America Follicular Lymphoma Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Boehringer Ingelheim GmbH
      • 12.1.1 Boehringer Ingelheim GmbH Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Follicular Lymphoma Treatment Introduction
      • 12.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.1.5 Boehringer Ingelheim GmbH Recent Development
    • 12.2 Bristol-Myers Squibb Company
      • 12.2.1 Bristol-Myers Squibb Company Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Follicular Lymphoma Treatment Introduction
      • 12.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.2.5 Bristol-Myers Squibb Company Recent Development
    • 12.3 Celgene Corporation
      • 12.3.1 Celgene Corporation Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Follicular Lymphoma Treatment Introduction
      • 12.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.3.5 Celgene Corporation Recent Development
    • 12.4 Celldex Therapeutics, Inc.
      • 12.4.1 Celldex Therapeutics, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Follicular Lymphoma Treatment Introduction
      • 12.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.4.5 Celldex Therapeutics, Inc. Recent Development
    • 12.5 Celltrion, Inc.
      • 12.5.1 Celltrion, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Follicular Lymphoma Treatment Introduction
      • 12.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.5.5 Celltrion, Inc. Recent Development
    • 12.6 Cellular Biomedicine Group, Inc.
      • 12.6.1 Cellular Biomedicine Group, Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Follicular Lymphoma Treatment Introduction
      • 12.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.6.5 Cellular Biomedicine Group, Inc. Recent Development
    • 12.7 Coherus BioSciences, Inc.
      • 12.7.1 Coherus BioSciences, Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Follicular Lymphoma Treatment Introduction
      • 12.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.7.5 Coherus BioSciences, Inc. Recent Development
    • 12.8 CTI BioPharma Corp.
      • 12.8.1 CTI BioPharma Corp. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Follicular Lymphoma Treatment Introduction
      • 12.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.8.5 CTI BioPharma Corp. Recent Development
    • 12.9 Curis, Inc.
      • 12.9.1 Curis, Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Follicular Lymphoma Treatment Introduction
      • 12.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.9.5 Curis, Inc. Recent Development
    • 12.10 Dynavax Technologies Corporation
      • 12.10.1 Dynavax Technologies Corporation Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Follicular Lymphoma Treatment Introduction
      • 12.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2014-2019)
      • 12.10.5 Dynavax Technologies Corporation Recent Development
    • 12.11 Eisai
    • 12.12 EpiZyme, Inc.
    • 12.13 F. Hoffmann-La Roche Ltd.
    • 12.14 Genentech, Inc.
    • 12.15 Gilead Sciences, Inc.
    • 12.16 GlaxoSmithKline Plc
    • 12.17 Hutchison MediPharma Limited
    • 12.18 Immune Design Corp.
    • 12.19 ImmunoGen, Inc.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Follicular Lymphoma Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Follicular Lymphoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Follicular Lymphoma Treatment development in United States, Europe and China.

      The key players covered in this study
      Boehringer Ingelheim GmbH
      Bristol-Myers Squibb Company
      Celgene Corporation
      Celldex Therapeutics, Inc.
      Celltrion, Inc.
      Cellular Biomedicine Group, Inc.
      Coherus BioSciences, Inc.
      CTI BioPharma Corp.
      Curis, Inc.
      Dynavax Technologies Corporation
      Eisai
      EpiZyme, Inc.
      F. Hoffmann-La Roche Ltd.
      Genentech, Inc.
      Gilead Sciences, Inc.
      GlaxoSmithKline Plc
      Hutchison MediPharma Limited
      Immune Design Corp.
      ImmunoGen, Inc.

      Market segment by Type, the product can be split into
      Chemotherapy
      Radiotherapy
      Monoclonal Antibodies
      Stem Cell Transplantation

      Market segment by Application, split into
      Hospital
      Clinic
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Follicular Lymphoma Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Follicular Lymphoma Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Follicular Lymphoma Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now